InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-6.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Zordani Richard A. Jr., Director. Officer active across 1 company, notably Galectin Therapeutics INC. In total, 6 disclosures have been logged. Split: 6 buys · 0 sell. Total volume traded: €42k. History available since 14 January 2022. The latest transaction was filed on 24 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Zordani Richard A. Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
10,000 shares@ US$0.816415.6% of flowCommon StockSEC:0001133416-24-000066:0
Canonical exit: 24 Mar 2025 (T+90)
1,000 shares@ US$2.304.1% of flowCommon StockSEC:0001133416-24-000054:0
Canonical exit: 21 Nov 2024 (T+90)
1,000 shares@ US$3.526.5% of flowCommon StockSEC:0001133416-24-000042:0
Canonical exit: 29 Jul 2024 (T+90)
5,000 shares@ US$2.5024.3% of flowCommon StockSEC:0001133416-22-000073:0
Canonical exit: 26 Oct 2022 (T+90)
5,000 shares@ US$1.60517.6% of flowCommon StockSEC:0001133416-22-000053:0
Canonical exit: 3 Jul 2022 (T+90)
5,000 shares@ US$2.0221.2% of flowCommon StockSEC:0001133416-22-000006:0
Canonical exit: 14 Apr 2022 (T+90)
6 of 6 declarations
About Zordani Richard A. Jr.
Zordani Richard A. Jr. is Administrateur at Galectin Therapeutics INC (XNAS). The record shows 6 filings in total, and across the 6 sampled recent filings, acquisitions for EUR 41606 between 2022-01-18 and 2024-12-26, with no sales reported.
